Montreal Neurological InstituteJeanne Timmins Amphitheatre, 3801 rue University, Montreal, QC, H3A 2B4, CA
This conference will focus on the roles played by ligand-gated signaling in epileptiform synchronization and epileptogenesis. A Faculty of prominent researchers from Canada, Europe and USA will gather at the Montreal Neurological Institute of McG
Montreal Neurological Institute and HospitalJeanne Timmins Amphitheatre, 3801 University Street, H3A 2B4
Professor Emmanuelle Charpentier, Director at the Max Planck Institute for Infection Biology in Berlin, Germany will deliver the 2016 Gairdner National Program Lecture entitled ‘The Transformative Genome Engineering CRISPR-Cas9 Technology: Mechanism
Montreal Neurological Institute and HospitalThe de Grandpré Communications Centre, 3801 University Street, H3A 2B4
The course will provide clinicians and scientists working in epilepsy with an understanding of fundamentals and practical skills related to neuroimaging. The course welcomes both individuals with and those without prior expertise in neuroimaging.
Research underlines importance of computational power in future neurological breakthrough
Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.
A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.
Using both cellular and mouse models, the team has shown that proteins produced by the two genes, known as PINK1 and Parkin, are required to prevent cells from being detected and attacked by the immune system.
The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS), and urges all to help support ALS research.
Every ten minutes, someone in Canada suffers a stroke. Strokes kill 14,000 Canadians each year, making stroke the third leading cause of death in this country.
The Montreal Neurological Institute and Hospital (The Neuro) hopes to increase public awareness about the dangers of stroke by marking Stroke Month. People who learn about the causes of stroke can take measures to reduce their chances of having a stroke.
Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.
It is estimated that between two and 10 people per 100,000 in the general population have HSP, a disease characterized by weakness or spasticity in the lower limbs. HSP is caused by mutations inherited from one or both parents.
''The Wounded Brain Healed - The Golden Age of the Montreal Neurological Institute, 1934-1984" by William Feindel and Richard Leblanc is now available for purchase from McGill-Queen's University Press.
Multiple sclerosis treatment and research has long been a focus at the Montreal Neurological Institute and Hospital, known simply as The Neuro, an illustrious member of McGill University and the McGill University Health Centre. Indeed, The Neuro introduced Canada’s first MS clinic. The clinic’s highly specialized staff employs the latest research data and treatment methods in a clinical atmosphere of innovation and progress.